Applied Therapeutics Inc (NASDAQ: APLT) on Friday, soared 1.52% from the previous trading day, before settling in for the closing price of $4.60. Within the past 52 weeks, APLT’s price has moved between $1.18 and $9.39.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 12.40%. With a float of $88.20 million, this company’s outstanding shares have now reached $114.27 million.
The firm has a total of 25 workers. Let’s measure their productivity.
Applied Therapeutics Inc (APLT) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Applied Therapeutics Inc is 22.81%, while institutional ownership is 72.60%. The most recent insider transaction that took place on Jun 06 ’24, was worth 266,954. In this transaction President and CEO of this company sold 61,795 shares at a rate of $4.32, taking the stock ownership to the 3,756,019 shares. Before that another transaction happened on Jun 06 ’24, when Company’s Chief Medical Officer sold 22,003 for $4.32, making the entire transaction worth $95,053. This insider now owns 1,009,534 shares in total.
Applied Therapeutics Inc (APLT) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 12.40% per share during the next fiscal year.
Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators
Applied Therapeutics Inc (APLT) is currently performing well based on its current performance indicators. A quick ratio of 1.80 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 50.06.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.32, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.46 in one year’s time.
Technical Analysis of Applied Therapeutics Inc (APLT)
Analysing the last 5-days average volume posted by the [Applied Therapeutics Inc, APLT], we can find that recorded value of 3.53 million was better than the volume posted last year of 1.62 million. As of the previous 9 days, the stock’s Stochastic %D was 35.28%. Additionally, its Average True Range was 0.33.
During the past 100 days, Applied Therapeutics Inc’s (APLT) raw stochastic average was set at 30.64%, which indicates a significant decrease from 35.88% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 63.22% in the past 14 days, which was lower than the 109.42% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.50, while its 200-day Moving Average is $3.79. Now, the first resistance to watch is $4.82. This is followed by the second major resistance level at $4.98. The third major resistance level sits at $5.15. If the price goes on to break the first support level at $4.49, it is likely to go to the next support level at $4.32. Now, if the price goes above the second support level, the third support stands at $4.16.
Applied Therapeutics Inc (NASDAQ: APLT) Key Stats
Market capitalization of the company is 533.64 million based on 114,267K outstanding shares. Right now, sales total 9,990 K and income totals -119,760 K. The company made 190 K in profit during its latest quarter, and -83,940 K in sales during its previous quarter.
